DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Cytarabine side effects in male

Reported by a physician from France on 2012-08-07

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Anaemia, Febrile Bone Marrow Aplasia, Erythema, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 1330 milligram
    Start date: 2012-04-18
    End date: 2012-04-24

Ccnu
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-04-18

Idarubicin HCL
    Start date: 2012-04-18
    End date: 2012-04-22

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-28

Cytarabine
    Start date: 2012-04-18
    End date: 2012-04-24

Other drugs received by patient: Bisoprolol Fumarate; Rocephin; Amikacin



Possible Cytarabine side effects in

Reported by a physician from France on 2012-08-01

Patient:

Reactions: Hyperthermia, Embolism, Anaemia, General Physical Health Deterioration, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vorinostat-Mycosis Fungoides
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-02-15
    End date: 2011-02-28

Vorinostat-Mycosis Fungoides
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-03-21
    End date: 2011-04-03

Cytarabine
    Dosage: 18.4 mg, qd
    Start date: 2011-02-15
    End date: 2011-02-28

Cytarabine
    Dosage: 36.8 mg, qd
    Start date: 2011-03-21
    End date: 2011-04-06

Other drugs received by patient: Plavix; Preterax (Indapamide (+) Perindopril Erbumine); Vfend; Omeprazole



Possible Cytarabine side effects in 24 year old female

Reported by a consumer/non-health professional from United States on 2012-07-30

Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)

Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Sprycel
    Dosage: last dose on 26jun12
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Cytarabine
    Dosage: last dose:17jun12 route:intra ommya
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Vincristine Sulfate
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Filgrastim
    Dosage: last dose:18jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17
    End date: 2012-01-01

Leucovorin Calcium
    Dosage: last dose :21may12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Methotrexate
    Dosage: last dose:13jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Dexamethasone
    Dosage: last dose:16jun12
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Doxorubicin HCL
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Mesna
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Cyclophosphamide
    Dosage: last dose on 16jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Methylprednisolone
    Dosage: last dose:21may12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17



Possible Cytarabine side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 46 year old female

Reactions: Pain in Extremity, Unresponsive To Stimuli, Anaemia, Pallor, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Diarrhoea Haemorrhagic, Blood Culture Positive, Small Intestinal Haemorrhage, Asthenia, Apnoea, Hepatosplenomegaly, Candidiasis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Oncovin
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide

Idarubicin HCL
    Dosage: 12 mg/d/m2 (1 cycle)

Rituximab
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Melphalan Hydrochloride

Vorinostat
    Dosage: 1 cycle
    Administration route: Oral

Cyclophosphamide
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine

Rituximab

Carmustine

Cytarabine
    Dosage: 1.5 g/d/m2 (1 cycle)



Possible Cytarabine side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 46 year old female

Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Carmustine

Idarubicin HCL
    Dosage: 12 mg/d/m2 (1 cycle)

Rituximab
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine

Melphalan Hydrochloride

Cytarabine
    Dosage: 1.5 g/d/m2 (1 cycle)

Oncovin
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide

Rituximab

Doxorubicin Hydrochloride
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Vorinostat
    Dosage: 1 cycle
    Administration route: Oral



Possible Cytarabine side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 46 year old female

Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Dosage: 12 mg/m2, unk
    Indication: Myelodysplastic Syndrome

Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Suberoylanilide Hydroxamic Acid
    Dosage: 500 mg, tid
    Administration route: Oral
    Indication: Myelodysplastic Syndrome

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Oncovin
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Radiotherapy



Possible Cytarabine side effects in male

Reported by a physician from France on 2012-07-27

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Anaemia, Febrile Bone Marrow Aplasia, Thrombocytopenia, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-28

Vidaza
    Dosage: 1330 milligram
    Start date: 2012-04-18
    End date: 2012-04-24

Cytarabine
    Start date: 2012-04-18
    End date: 2012-04-24

Ccnu
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-04-18

Idarubicin HCL
    Start date: 2012-04-18
    End date: 2012-04-22

Other drugs received by patient: Bisoprolol Fumarate; Amikacin; Rocephin



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-27

Patient:

Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Rash, Fatigue, Aspartate Aminotransferase Increased, Adverse Event, Neutropenia, Rash Maculo-Papular, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Revlimid
    Dosage: 50 milligram
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Cytarabine
    Dosage: 1.5 milligram/sq. meter

Cytarabine
    Dosage: 10 milligram



Possible Cytarabine side effects in 38 year old female

Reported by a physician from United States on 2012-06-25

Patient: 38 year old female

Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate Sodium
    Dosage: 1880 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Leucovorin Calcium
    Dosage: 125 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Cytarabine
    Dosage: 5640 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Methylprednisolone
    Dosage: 300 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Sprycel
    Dosage: 980 mg, unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from Italy on 2012-06-18

Patient: male

Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Vincristine Sulfate
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-06-14

Patient: male

Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Drug(s) suspected as cause:
Carmustine
    Indication: Burkitt's Lymphoma

Carboplatin
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Melphalan Hydrochloride
    Indication: Burkitt's Lymphoma

Radiotherapy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Unknown Medication
    Dosage: antimicrobial prophylaxis
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-06-11

Patient: male

Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Erythema, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cisplatin
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Tenormin; Dexamethasone Sodium Phosphate; Lasix; Navoban; Ramipril; Trimeton; Levothyroxine Sodium; Aspirin



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-06-08

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Oncaspar
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole



Possible Cytarabine side effects in 69 year old male

Reported by a physician from Italy on 2012-06-07

Patient: 69 year old male

Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Thrombocytopenia, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 200 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Dosage: 4000 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Mabthera
    Dosage: 700 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Levothyroxine Sodium; Ramipril; Lasix; Tenormin; Trimeton; Navoban; Aspirin; Dexamethasone Sodium Phosphate



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: male, weighing 102.6 kg (225.7 pounds)

Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 1600 mg, cyclic
    End date: 2011-07-28

Adriamycin PFS
    Dosage: 101 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-05

Rituximab
    Dosage: 750 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Methotrexate
    Dosage: 400 mg, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-27

Cytarabine
    Dosage: 6 g, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-30

Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 20 unk, unk
    Administration route: Oral
    End date: 2011-07-15

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-12

Velcade
    Dosage: 2.6 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Cyclophosphamide
    Dosage: 603 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-02
    End date: 2011-07-04

Other drugs received by patient: Filgrastim; Ferrous Sulfate TAB; Heparin; Senokot; Triamcinolone Acetonide; Compazine; Ciprofloxacin; Fluconazole; Omeprazole; Mesna; Prevident; Valtrex; Vitamin C / 00008001 /; Methylprednisolone; Periogard; Ultram; Vitamin D



Possible Cytarabine side effects in 1 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28

Patient: 1 year old female, weighing 1.0 kg (2.2 pounds)

Reactions: Foetal Growth Restriction, Foetal Distress Syndrome, Premature Baby, Sepsis, Anaemia, Leukopenia

Drug(s) suspected as cause:
Cytarabine

Etoposide
    Dosage: days 8-10

Daunorubicin HCL



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-05-24

Patient: male, weighing 103.3 kg (227.3 pounds)

Reactions: Rectal Haemorrhage, Anaemia, Blood Blister, Petechiae, Headache, Haemolysis, Dysgeusia, Ecchymosis, Thrombocytopenia, Papule

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mercaptopurine
    Dosage: 3900 mg

Cytarabine
    Dosage: 2890 mg

Cyclophosphamide
    Dosage: 4600 mg

Methotrexate
    Dosage: 60 mg

PEG-L-Asparaginase (K-H)
    Dosage: 5700 unit

Vincristine Sulfate
    Dosage: 4 mg



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-05-14

Patient: male, weighing 103.3 kg (227.3 pounds)

Reactions: Oral Mucosal Blistering, Anaemia, Rash Papular, Blood Blister, Headache, Haemolysis, Dysgeusia, Haemoglobin Decreased, Ecchymosis, Platelet Count Decreased, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytoxan
    Dosage: 4600 mg

Cytarabine
    Dosage: 2890 mg

Vincristine Sulfate
    Dosage: 4 mg

PEG-L -Asparaginase (K-H)
    Dosage: 5700 unit

Methotrexate
    Dosage: 60 mg

Mercaptopurine
    Dosage: 3900 mg



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-05-11

Patient:

Reactions: Hypersensitivity, Petechiae, Off Label Use, Neurotoxicity, Hepatotoxicity, Granulocytopenia, Bone Marrow Failure, White Blood Cell Count Decreased, Gastrointestinal Toxicity, Anaemia, Nephropathy Toxic, Urinary Tract Infection, Toxicity To Various Agents, Soft Tissue Infection, Sepsis, Platelet Count Decreased, Infection

Drug(s) suspected as cause:
Mesna
    Indication: Acute Myeloid Leukaemia

Epirubicin
    Indication: non-Hodgkin's Lymphoma

Epirubicin
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Vindesine
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Vindesine
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Mesna
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Leucovorin Calcium



Possible Cytarabine side effects in 69 year old male

Reported by a physician from Italy on 2012-05-10

Patient: 69 year old male

Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Erythema, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Dosage: 700 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Dosage: 4000 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cisplatin
    Dosage: 200 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Ramipril; Lasix; Aspirin; Navoban; Tenormin; Trimeton; Dexamethasone Sodium Phosphate; Levothyroxine Sodium



Possible Cytarabine side effects in 71 year old male

Reported by a physician from Japan on 2012-05-10

Patient: 71 year old male

Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Anaemia, Platelet Count Decreased, Pleural Effusion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Sprycel
    Dosage: 70 mg, 2x/day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-22

Neupogen
    Indication: Acute Lymphocytic Leukaemia

Oncovin
    Indication: Acute Lymphocytic Leukaemia

Idarubicin HCL
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-08
    End date: 2012-02-15

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-08
    End date: 2012-02-15

Other drugs received by patient: Candesartan Cilexetil; Dexamethasone Sodium Phosphate; Fluconazole; Allopurinol; Polymyxin B Sulfate; Cotrim; Neutrogin



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-05-10

Patient:

Reactions: Hypersensitivity, Neurotoxicity, Off Label Use, Hepatotoxicity, Granulocytopenia, Bone Marrow Failure, White Blood Cell Count Decreased, Gastrointestinal Toxicity, Nephropathy Toxic, Urinary Tract Infection, Anaemia, Soft Tissue Infection, Acute Lymphocytic Leukaemia, Sepsis, Platelet Count Decreased, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Mesna
    Indication: Acute Myeloid Leukaemia

Methotrexate
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Mesna
    Indication: non-Hodgkin's Lymphoma

Vindesine
    Indication: Acute Lymphocytic Leukaemia

Vindesine
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone TAB
    Indication: non-Hodgkin's Lymphoma

Dexamethasone TAB
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Leucovorin Calcium



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-05-10

Patient: male

Reactions: Renal Failure, Pruritus, Anaemia, Hypocalcaemia, Thrombocytopenia, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cisplatin
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Dexamethasone Sodium Phosphate; Trimeton; Levothyroxine Sodium; Tenormin; Ramipril; Navoban; Lasix; Aspirin



Possible Cytarabine side effects in 69 year old male

Reported by a physician from Italy on 2012-05-08

Patient: 69 year old male

Reactions: Renal Failure, Pruritus, Anaemia, Hypocalcaemia, Erythema, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 200 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Mabthera
    Dosage: 700 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cytarabine
    Dosage: 4000 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Dexamethasone Sodium Phosphate; Lasix; Trimeton; Ramipril; Aspirin; Navoban; Tenormin; Levothyroxine Sodium



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-05-03

Patient: male

Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Thrombocytopenia, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Mabthera
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Cisplatin
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-14
    End date: 2012-04-26

Other drugs received by patient: Lasix; Trimeton; Tenormin; Aspirin; Ramipril; Dexamethasone Sodium Phosphate; Levothyroxine Sodium; Navoban



Possible Cytarabine side effects in 87 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: 87 year old female, weighing 51.3 kg (112.9 pounds)

Reactions: Fluid Overload, Confusional State, Urinary Tract Infection, Anaemia, Syncope, Fungal Infection, Pleural Effusion, Hypoxia, Thrombocytopenia, Pathogen Resistance, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-03-29
    End date: 2010-04-02

Decitabine
    Dosage: 20 mg/m2, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-02-27
    End date: 2010-03-03

Granulocyte Colony Stimulating Ractor (Granulocyte Colony Stimalating
    Dosage: 300 mg, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-02-27
    End date: 2010-03-03

Granulocyte Colony Stimulating Ractor (Granulocyte Colony Stimalating
    Dosage: 300 mg, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-03-29
    End date: 2010-04-02

Cytarabine
    Dosage: 20 mg/m2, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-02-27
    End date: 2010-03-03

Cytarabine
    Dosage: 20 mg/m2, subcutaneous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-03-29
    End date: 2010-04-02

Other drugs received by patient: Prilosec; Voriconazole; Neutra Phos (Neutra-Phos); Reglan; Potassium Chloride; Propranolol



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-04-18

Patient: male, weighing 102.6 kg (225.7 pounds)

Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 101 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-05

Velcade
    Dosage: 2.6 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Methotrexate
    Dosage: 400 mg, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-27

Methotrexate
    Dosage: 1600 mg, cyclic
    End date: 2011-07-28

Cytarabine
    Dosage: 6 g, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-30

Dexamethasone
    Dosage: 20 unk, unk
    Administration route: Oral
    End date: 2011-07-15

Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Dosage: 603 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-02
    End date: 2011-07-04

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-12

Rituximab
    Dosage: 750 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Other drugs received by patient: Periogard; Senokot; Compazine; Triamcinolone Acetonide; Valtrex; Fluconazole; Prevident; Ferrous Sulfate TAB; Filgrastim; Ciprofloxacin Hydrochloride; Heparin; Methylprednisolone; Vitamin C / 00008001 /; Vitamin D; Omeprazole; Ultram; Mesna



Possible Cytarabine side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12

Patient: 58 year old female

Reactions: Cellulitis, Contusion, Anaemia, Febrile Neutropenia, Hidradenitis, Pallor, Fatigue, Staphylococcal Infection, Thrombocytopenia, Papule

Drug(s) suspected as cause:
Cytarabine
    Dosage: 2.6 mg/kg, 7 days
    Indication: Acute Myeloid Leukaemia

Daunorubicin HCL
    Dosage: 1.5 mg/kg, 3 days
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-26

Patient: 62 year old male, weighing 87.0 kg (191.4 pounds)

Reactions: Atrial Tachycardia, Cardio-Respiratory Arrest, Anaemia, Ventricular Fibrillation, Cardiac Arrest

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Mantle Cell Lymphoma Stage IV
    Start date: 2011-12-12

Carboplatin
    Dosage: 700 mg, cyclic
    Start date: 2012-01-02
    End date: 2012-01-02

Cytarabine
    Dosage: 4000 mg/m2, 1x/day
    Start date: 2012-01-03
    End date: 2012-01-04

Dexamethasone Sodium Phosphate
    Dosage: unk
    Indication: Mantle Cell Lymphoma Stage IV
    Start date: 2011-12-12

Mabthera
    Dosage: 900 mg, cyclic
    Start date: 2012-01-02
    End date: 2012-01-02

Mabthera
    Dosage: unk
    Indication: Mantle Cell Lymphoma Stage IV
    Start date: 2011-12-12

Dexamethasone Sodium Phosphate
    Dosage: 40 mg, single
    Start date: 2012-01-04
    End date: 2012-01-04

Carboplatin
    Dosage: 700 mg, once per cycle
    Indication: Mantle Cell Lymphoma Stage IV
    Start date: 2011-12-12

Other drugs received by patient: Methylprednisolone



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014